Biostax Corp. (BTAX)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
May 8, 2025, 9:30 AM EDT
Biostax Statistics
Total Valuation
Biostax has a market cap or net worth of 17,264. The enterprise value is 1.18 million.
Market Cap | 17,264 |
Enterprise Value | 1.18M |
Important Dates
The last earnings date was Wednesday, April 23, 2025.
Earnings Date | Apr 23, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Biostax has 86.32 million shares outstanding. The number of shares has increased by 0.93% in one year.
Current Share Class | 86.32M |
Shares Outstanding | 86.32M |
Shares Change (YoY) | +0.93% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | 34.30% |
Owned by Institutions (%) | n/a |
Float | 53.02M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -0.00 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | 0.14 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.63 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3.33 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -164.58% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 18.24% |
Revenue Per Employee | n/a |
Profits Per Employee | -467,582 |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.38% in the last 52 weeks. The beta is 0.82, so Biostax's price volatility has been lower than the market average.
Beta (5Y) | 0.82 |
52-Week Price Change | -99.38% |
50-Day Moving Average | 0.00 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 1.03 |
Average Volume (20 Days) | 68 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.00 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -971,046 |
Pretax Income | -1.87M |
Net Income | -1.87M |
EBITDA | -916,538 |
EBIT | -971,046 |
Earnings Per Share (EPS) | -0.02 |
Balance Sheet
Cash & Cash Equivalents | n/a |
Total Debt | 1.16M |
Net Cash | -1.16M |
Net Cash Per Share | -0.01 |
Equity (Book Value) | -5.32M |
Book Value Per Share | -0.06 |
Working Capital | -5.33M |
Cash Flow
Operating Cash Flow | 125,025 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Biostax does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.93% |
Shareholder Yield | -0.93% |
Earnings Yield | -10,833.69% |
FCF Yield | n/a |
Stock Splits
The last stock split was on May 6, 2021. It was a reverse split with a ratio of 0.001.
Last Split Date | May 6, 2021 |
Split Type | Reverse |
Split Ratio | 0.001 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |